Markets
H.C. Wainwright Reiterates Buy on Caribou Biosciences: What Traders Need to Know Now
H.C. Wainwright has reiterated its Buy rating on Caribou Biosciences, reinforcing conviction in the gene-editing biotech at a pivotal moment for both clinical progress and sector sentiment. Here's what the call means for traders and investors across all time horizons.